Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A phase 2/3 study of Thykamine in pediatric patient population with mild-to-moderate atopic dermatitis

Next Previous
Search
Trial Profile

A phase 2/3 study of Thykamine in pediatric patient population with mild-to-moderate atopic dermatitis

Status: Planning
Phase of Trial: Phase II/III

Latest Information Update: 09 Jun 2023

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Thykamine (Primary)
  • Indications Atopic dermatitis
  • Focus Adverse reactions; Therapeutic Use

    • Most Recent Events

    • 06 Jun 2023 According to a Devonian media release, the company announce that it has closed its non-brokered previously announced private placement for aggregate gross proceeds of $1,199,664.75.The proceeds of the Offering will mainly be used to finance the preparation of clinical study programs for Thykamine™ in particular the phase 2/3 program in pediatric atopic dermatitis, the phase 2 programs in radiodermatitis associated with radiotherapy.
    • 19 May 2023 New trial record
    • 16 May 2023 According to a Devonian media release, company is establishing its final formulation manufacturing activities in a leading global contract development and manufacturing. The transfer and validation process should be completed within the next months. Devonian will then, as a priority, file to regulatory agencies for this study.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top